Holen Sie sich die Stockscreener-App
11.48
4.48%
0.77
Schlusskurs vom Vortag:
$10.71
Offen:
$11.09
24-Stunden-Volumen:
14,561
Relative Volume:
0.66
Marktkapitalisierung:
$120.23M
Einnahmen:
$72.33M
Nettoeinkommen (Verlust:
$-8.38M
KGV:
-14.57
EPS:
-0.7881
Netto-Cashflow:
$-4.95M
1W Leistung:
+22.30%
1M Leistung:
+27.01%
6M Leistung:
-50.22%
1J Leistung:
+18.04%
1-Tages-Spanne:
$10.85
$12.01
1-Wochen-Bereich:
$9.28
$12.46
52-Wochen-Spanne:
$6.79
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Firmenname
Burning Rock Biotech Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare BNR vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
11.40 | 112.95M | 72.33M | -8.38M | -4.95M | -0.7881 |
TMO
Thermo Fisher Scientific Inc
|
603.56 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.21 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
324.81 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
256.66 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
518.88 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Aktie (BNR) Neueste Nachrichten
Aesthetic Medical International Holdings Group Ltd (AIH) Peer Comparison – Compare with Others - Value Research
Concord Medical Services Holdings LimitedADR Peer Comparison – Compare with Others - Value Research
Burning Rock Biotech Ltd StockBNR Share Price Today, News and Discussion - Stocktwits
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 3.7%What's Next? - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – FWB:6BU0 - TradingView
Burning Rock Biotech Limited Sponsored ADR $BNR Shares Sold by Crcm LP - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to EBITDA forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Burning Rock CEO purchases $618,218 in company shares - Investing.com
Burning Rock Announces Founder’s Purchase of Its ADSs - Barchart.com
Burning Rock Biotech Ltd. Sponsored ADR Financial Disclosures & Filings - TradingView
Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to book forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to earnings forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:BNR) - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (LS:A40AE6) - TradingView
Why These High-Flying Stocks Came Back To Earth - Sahm
BNRBurning Rock Biotech Ltd ADR Stock Price and Quote - Finviz
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Momentum ETF - newsline.com
ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks - TradingView
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Burning Rock Biotech (NASDAQ: BNR) 2025 loss narrows amid China and HFCAA risks - Stock Titan
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 1.3%What's Next? - MarketBeat
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
(BNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Burning Rock Biotech (BNR) Stock Price, News & Analysis $BNR - MarketBeat
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results - Barchart.com
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Australia
Intel, Iris Energy among market cap stock movers on Friday - Investing.com
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
Burning Rock Announces Results of 2025 Annual General Meeting - Barchart.com
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Yahoo Finance
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - Barchart.com
KindlyMD (NAKA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
BNR: Revenue up 9.6% and net loss narrowed, with strong pharma R&D and cost controls - TradingView
BNR: Net loss narrowed 89% year-over-year as pharma R&D revenue surged and margins improved - TradingView
BNR: 2024 revenue fell 4% to RMB515.8M, net loss narrowed 47%, in-hospital segment now leads - TradingView
BNR: Commercial breakeven reached in FY2024, with strong margins and leadership in early cancer detection - TradingView
BNR: Net loss narrowed and gross margin improved as in-hospital and pharma R&D revenues grew - TradingView
BNR: In-hospital revenue rose 11.2% and net loss narrowed as the business shifted away from central-lab testing - TradingView
Japan Multi Cancer Early Detection Market Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Share Price ADR Each Representing 10 Ord A Shares SPON - Hargreaves Lansdown
Finanzdaten der Burning Rock Biotech Ltd Adr-Aktie (BNR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Burning Rock Biotech Ltd Adr-Aktie (BNR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Han Yusheng | Director |
Jun 12 '26 |
Buy |
9.25 |
210,000 |
1,942,143 |
17,907,436 |
| Han Yusheng | Director |
Jun 16 '26 |
Buy |
9.00 |
111,110 |
999,957 |
18,018,546 |
| Han Yusheng | Director |
Jun 22 '26 |
Buy |
7.45 |
104,650 |
779,674 |
18,123,196 |
| Han Yusheng | Director |
Jun 11 '26 |
Buy |
8.74 |
24,760 |
216,388 |
17,697,436 |
| Han Yusheng | Director |
Jun 26 '26 |
Buy |
8.00 |
24,900 |
199,090 |
18,404,086 |
| Han Yusheng | Director |
Jun 23 '26 |
Buy |
7.50 |
5,990 |
44,920 |
18,129,186 |
| Han Yusheng | Director |
Mar 31 '26 |
Buy |
17.36 |
314,870 |
5,466,143 |
17,672,676 |
1.07%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):